Both in Pharmaceuticals
Eli Lilly & vs Pfizer
Over the past year LLY returned +64.3% and PFE returned +23.8%; their daily moves had a correlation of 0.44.
LLY +64.3% PFE +23.8%Growth of $1, one year, split-adjusted
| Metric | LLY | PFE |
|---|---|---|
| Price | $1,417.54 | $30.52 |
| Market cap | $1.26T | $173.95B |
| Today | +3.19% | +1.90% |
| 1 month | +23.3% | +8.5% |
| 6 months | +47.1% | +15.9% |
| Year to date | +31.9% | +22.6% |
| 1 year | +74.2% | +25.6% |
| Revenue growth (YoY) | +38.6% | +2.6% |
| Gross margin | 83.9% | 72.8% |
| Net margin | 26.4% | −1.6% |
| P/E (TTM) | 45.8× | 40.2× |
| Price / sales | 14.6× | 2.7× |
| Net cash | -$44.62B | -$51.49B |
| Dividend yield | 0.49% | 5.64% |
| Volatility (60d) | 30.8% | 19.8% |
| Short % of float | 0.8% | 2.4% |
| Next earnings | — | Nov 3, 2026 |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).